People Science™ and Sen-Jam Pharmaceutical partner to develop people-forward tools to study inflammation, pain, and opioid withdrawal symptoms in the real world


The partnership leverages comprehensive virtual clinical research technology in forward-thinking research to advance the science of pain and inflammation.

LOS ANGELES and HUNTINGTON, New York, September 22, 2022 /PRNewswire/ — Folk Science, a direct-to-consumer scientific research company offering a scaled R&D platform for alternative medicines, and Sen-Jam Pharmaceutical, a drug development company developing novel solutions for pain and inflammation, today announce a partnership to develop tools for healthcare providers and Known to track, monitor and understand the effects of treatments on their health in the real world. Using a data-driven and people-centric approach, People Science will develop protocols and workflows developed in collaboration with experts in opioid use disorders and inflammatory diseases. People Science’s proprietary CHLOE software technology, the Consumer Health Learning and Organizing Ecosystem, will enable both healthcare providers and their patients to track symptoms, outcomes, quality of life and response to various therapies and approaches. CHLOE is a highly customizable, modular software technology that combines a consumer-facing mobile app with a rigorous, high-quality clinical research platform. People Science will then work with dedicated clinicians and their patients to prototype the applicability and usefulness of this tool in daily practice in the clinics and at home.

Also Read :  Avoid dual agency representation in real estate deals

“We are excited to be collaborating with People Science as our missions are precisely aligned to drive advances that put people at the center of results collection.” said Jackie Iversen, RPh, MS, Co-Founder and Head of Clinical Development at Sen-Jam. “The number one reason a person cannot break out of the grip of opioid use is the devastating withdrawal symptoms. We believe our product can radically reduce these symptoms using a safe and effective non-opioid product. This partnership promises to free independent trials to a preclinical level for so many who desperately need it.”

Increasing attention is being paid to the worsening drug epidemic in both prescription opioids and illicit substitutes. Recently, the American Medical Association released a report that found treatment barriers have worsened in the nation’s drug overdose epidemic and called on industry stakeholders to take greater action to address it. The partnership between People Science and Sen-Jam Pharmaceutical is arguably a big step in that direction.

This approach will not only provide more diverse and relevant data on real-world interactions and standards of care in the management of inflammatory diseases, but also support patients to take an active role in tracking their symptoms and journey to health and well-being. This partnership reflects the shared vision of People Science and Sen-Jam to give people the tools to lead healthy, happier, pain-free and stress-free lives.

Also Read :  Materials faculty part of two new DOE Energy Frontier Research Centers

“We are excited to support Sen-Jam’s mission as it allows them to think creatively about this challenging societal issue and meaningfully engage with those who suffer most,” said Belinda TanMD, PhD, Co-Founder and Co-CEO of People Science, “This partnership represents a great use case of how CHLOE can enable a better understanding of how we care for people with pain and opiate use disorders.”

Using technology to bridge the communication gap between patients and healthcare providers has become the standard of clinical research in the face of global quarantine measures and the rapid adoption of telemedicine. Patients suffering from inflammatory diseases are well suited to flexible instruments that save costs, time and energy. Insights from CHLOE are used to advance the technology for patients and clinicians to find out what works best.

About People Science

human science is a non-profit company building a forward-thinking clinical research infrastructure to support the development, knowledge and understanding of alternative medicine and digital health solutions – things that can keep us healthy or improve us. We help customers determine if their products actually improve customer health and well-being. As a technology-enabled clinical research company, we also empower individuals to answer the question, “What works best for me?” via the proprietary CHLOE apartment People Science tests good ideas by supporting research with the people interested in those ideas. Learn more at People Science and follow People Science On Linkedin.

Also Read :  Danny Black: Introducing The Women Moving The Sports Collectibles Industry Forward

About Sen-Jam Pharmaceutical

Sen-Jam Pharmaceutical is a drug development and licensing company aiming to revolutionize pain and inflammation. Sen-Jam Pharmaceutical’s mission is to improve societal well-being through the development of therapeutics that are safe, effective and accessible to all. Sen-Jam is repurposing small molecules to develop novel therapeutics to address large unmet needs with a focus on improving clinical outcomes. Using patented proprietary technology and the accelerated 505(b)2 pathway, Sen-Jam has been on a mission to provide the next generation of anti-inflammatory relief since inventing aspirin 125 years ago. Learn more at www.sen-jam.com.

Contact:
human science
E-mail: [email protected]

SOURCE People Science, Inc.



Source link